Grace Therapeutics, Inc. (NASDAQ:GRCE) Cap table

Grace Therapeutics, Inc.

Cap table

Built by 6ix from Grace Therapeutics, Inc.’s releases · as of Nov 11, 2026

Common shares
21,035,930
Fully diluted
21,035,930

Fully diluted

LineSharesAs of
Common shares21,035,930Nov 11, 2026

Share count over time

CountShares
Nov 11, 202621,035,930
Sep 30, 202621,035,930